Buprenorphine Hydrochloride 70069-0027-05
- Manufacturer
- Somerset Therapeutics, Llc
- Dosage Form
- Injection
- Route
- Intramuscular And Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- February 11, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA219302
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | .324 mg/mL |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Selected Package
70069-0027-05Selected5 VIAL in 1 CARTON (70069-027-05) / 1 mL in 1 VIAL